Consistent with the results in vitro, EFNB2 knockdown markedly retarded tumor progression, whereas EFNB2 overexpression rigorously promoted tumor growth (Figure 5H-M and Figure S6G-I). The gene discussed is EFNB2; the disease is neoplasm.